New article: Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation https://t.co/ztdkhQ4Asr #lungcancer #oncology https://t.co/AlwK1YDBhO
906 followers
38 followers
RT @DrImranSheikh: Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK…
17,283 followers
Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation: Treatment of ALK-rearranged non-small cell lung cancer (NSCLC) with tyrosine kinase… #oncology https://t.co/BzlkExGcgF
6,531 followers
New research: Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation: Treatment of ALK-rearranged non-small cell lung cancer (NSCLC) with tyrosine kinase… https://t.co/7AtbrA